Life Science Nation Newsletter  |  December 17, 2015  |  Issue 142

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Dec. 10 - Dec. 16)
Seeks Series A-B Financing Rounds in Biotech and Medtech
Invests In Oncology Assets
Seeks Early and Growth Opportunities in HCIT and Diagnostics
Seeks Approved Devices and Phase III Therapeutics
In This Issue
LSN Videos
RESI Boston 2015 Investors Panel

Video Recap of RESI@TMCx 2015

RESI Innovation Challenge: Participating Startups Announced 
By Dennis Ford, Founder & CEO, LSN

The RESI Innovation Challenge received a record number of applicants this fall. LSN's scientific review board assessed and ranked all entrants across a wide range of criteria, from scientific novelty to strength of IP, to select the 30 strongest entrants. We'd now like to announce these successful applicants. These entrepreneurs have been selected by LSN's scientific validation team to receive a presentation space in the exhibit hall for the full day of the conference to showcase their innovations to investors and fellow entrepreneurs. We're excited to meet all these companies in person in the Exhibitor Hall at RESI, and we hope you'll join us there to vote for the very best of these cutting-edge life science startups...
Crowdfunding & Reg A+ Workshop: Hear From the Experts
By Laura Chess, Business Development, LSN

The SEC has just released the long awaited crowdfunding regulations on the heels of Regulation A+ that went effective in June. Together they create two new exciting pathways to raise capital for your growing life science company.
This workshop will take place at RESI San Francisco at 11am on January 12th. Whether you are raising $1 million or up to $50 million, hear from experts who can guide you through the process with practical advice to see if these new alternatives are right for you. You'll learn how to "Test the Waters" to assess potential investor interest, learn how to prepare the streamlined Form 1-A and how to create a market for your shares.
This RESI workshop will be presented by four experts in the field:
  • Byron Kalogerou, Partner, McDermott Will & Emery, Boston
  • Eric Orsic, Partner, McDermott Will & Emery, Chicago
  • Gordon Ruckdeschel, Vice President, Operations, Vintage
  • Margaret Chou, Assistant Vice President, OTC Markets Group
Redefining Early Stage Investments (RESI) Conference: Healthcare IT Investors Panel
By Shaoyu Chang, MD, MPH,  Senior Research Manager, LSN

At the intersection between life science and computer science, healthcare IT continues to attract strong interests from both camps. VC funds, big pharmas, and tech corporates are all actively seeking the next big thing in HCIT that would transform healthcare fundamentally.
Some of the biggest players in HCIT investment will speak at RESI San Francisco to share their expertise and advice with entrepreneurs. Moderated by Anne DeGheest, Founder of HealthTech Capital, the panel will feature:
  • Janhvi Patel, Business Development Manager, IBM Watson Ecosystem
  • Joel Krikston, Managing Director, Merck Global Health Innovation Fund
  • Lucian Iancovici, Investment Manager, Qualcomm Life Fund
  • Rich Simoni, Partner, Asset Management Ventures